- Home
- TLPH vs CELZ Comparison
TLPH vs CELZ Comparison
Compare TLPH & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- CELZ
- Stock Information
- Founded
- TLPH 2005
- CELZ 1998
- Country
- TLPH United States
- CELZ United States
- Employees
- TLPH N/A
- CELZ N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- TLPH Health Care
- CELZ Health Care
- Exchange
- TLPH Nasdaq
- CELZ Nasdaq
- Market Cap
- TLPH 11.1M
- CELZ 10.4M
- IPO Year
- TLPH 2011
- CELZ N/A
- Fundamental
- Price
- TLPH $1.25
- CELZ $5.20
- Analyst Decision
- TLPH Strong Buy
- CELZ
- Analyst Count
- TLPH 1
- CELZ 0
- Target Price
- TLPH $6.00
- CELZ N/A
- AVG Volume (30 Days)
- TLPH 480.8K
- CELZ 69.2K
- Earning Date
- TLPH 11-12-2025
- CELZ 11-12-2025
- Dividend Yield
- TLPH N/A
- CELZ N/A
- EPS Growth
- TLPH N/A
- CELZ N/A
- EPS
- TLPH N/A
- CELZ N/A
- Revenue
- TLPH $27,000.00
- CELZ $6,000.00
- Revenue This Year
- TLPH N/A
- CELZ N/A
- Revenue Next Year
- TLPH $14,533.26
- CELZ N/A
- P/E Ratio
- TLPH N/A
- CELZ N/A
- Revenue Growth
- TLPH N/A
- CELZ N/A
- 52 Week Low
- TLPH $0.38
- CELZ $1.69
- 52 Week High
- TLPH $1.45
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- TLPH 64.99
- CELZ 79.76
- Support Level
- TLPH $1.12
- CELZ $3.35
- Resistance Level
- TLPH $1.19
- CELZ $4.23
- Average True Range (ATR)
- TLPH 0.11
- CELZ 0.33
- MACD
- TLPH -0.01
- CELZ 0.17
- Stochastic Oscillator
- TLPH 59.83
- CELZ 100.00
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.